Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients
Erhöhte Inanspruchnahme des Gesundheitswesens und unterschiedliche Outcomes bei pädiatrischen Krebspatient:innen versus Nicht-Krebs-Patient:innen
Cancer Medicine · 2026-11 · 15 (11)
DOI: 10.1002/cam4.72459 ↗Auf einen Blick
Bei 2.810 Krebspatient:innen und 11.240 Nicht-Krebs-Patient:innen war die Inanspruchnahme des Gesundheitswesens in der Krebsgruppe höher. Auch die 6-Monats-Mortalität war höher.
Fragestellung
Beschreibt die Studie die Inanspruchnahme des Gesundheitswesens und 6-Monats-Outcomes bei pädiatrischen Krebs- versus Nicht-Krebs-Patient:innen?
Methode
Multizentrische retrospektive Studie mit OMOP CDM; pädiatrische Patient:innen 0–18 Jahre bei erster Medikamentengabe; Outcomes innerhalb von 6 Monaten.
Ergebnisse
Alle untersuchten Inanspruchnahme-Maße waren bei Krebspatient:innen häufiger. Größte Unterschiede: langer stationärer Aufenthalt RR 26,32 (95 %-KI 15,00–46,17), CT RR 23,59 (95 %-KI 19,24–28,92), Blutkultur RR 37,04 (95 %-KI 9,58–143,14), i.v. Medikation RR 17,69 (95 %-KI 8,75–35,75).
Schlussfolgerung der Autor:innen
Mit dem OMOP CDM fanden die Autor:innen eine höhere Inanspruchnahme des Gesundheitswesens und schlechtere klinische Outcomes bei pädiatrischen Krebspatient:innen als bei Nicht-Krebs-Patient:innen.
Kernaussagen
- Krebs: höhere Inanspruchnahme in allen untersuchten Bereichen
- Langer stationärer Aufenthalt, CT, Blutkultur und i.v. Medikation am stärksten erhöht
- 6-Monats-Mortalität bei Krebs höher: RR 38,37 (95 %-KI 12,91–114,04)
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 29.10.2026. Verfasst von Yujie Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Neoplasms, Patient Acceptance of Health Care. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) is a data standard that enables multicenter research. Primary objective was to describe the magnitude of healthcare utilization in pediatric cancer versus non‐cancer patients. Secondary objective was to compare 6‐month clinical outcomes related to abnormal lab tests and mortality.
Methods
In this multicenter retrospective study, we included pediatric patients 0–18 years at first medication administration. Cancer patients had a malignant neoplastic disease diagnosis and received chemotherapy. Index date was the first chemotherapy date. Non‐cancer patients were assigned analogous index dates based on randomly sampled first medication to chemotherapy intervals. Outcomes were measured within 6 months of index date. Healthcare utilization included encounters, procedures, radiology, lab tests, and medications.
Results
Among 2810 cancer and 11,240 non‐cancer patients, all evaluated healthcare utilization measures were significantly more common in cancer patients. The largest relative differences were observed for long inpatient stay (risk ratio [RR] 26.32, 95% confidence interval [CI] 15.00–46.17), computed tomography (RR 23.59, 95% CI 19.24–28.92), blood culture (RR 37.04, 95% CI 9.58–143.14), and intravenous medication (RR 17.69, 95% CI 8.75–35.75). Death within 6 months was higher for cancer versus non‐cancer patients (RR 38.37, 95% CI 12.91–114.04).
Conclusions
Using the OMOP CDM, we found greater healthcare utilization and worse clinical outcomes among pediatric cancer patients than non‐cancer patients, with the largest relative differences observed for inpatient stay, computed tomography, blood culture, and intravenous medication. These findings provide insight into resource utilization patterns and illustrate the OMOP CDM research potential for multicenter studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
- Columbia University School of Nursing/Herbert Irving Cancer Center, New York, New York, USA.
- Ben Towne Center for Childhood Cancer and Blood Disorders Research and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
- Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
- Stanford Center for Biomedical Informatics Research, Stanford University, Palo Alto, California, USA.
ORCID-Profile: Melissa P Beauchemin, Christine Cunningham, Jennifer Oberg, Karthik Natarajan, David Noyd, Vicki Soucek, Rhea K Khurana, Lillian Sung
Zitieren
APA
Chen, Y., Yi, M., Aftandilian, C. C., Beauchemin, M. P., Cunningham, C., Larimer, E., Oberg, J., May, B. L., Morse, K., Natarajan, K., Noyd, D., Soucek, V., Khurana, R. K., Sim, P., Guo, L. L., & Sung, L. (2026). Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72459
Vancouver
Chen Y, Yi M, Aftandilian CC, Beauchemin MP, Cunningham C, Larimer E, et al. Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72459
BibTeX
@article{Chen2026,
author = {Chen, Yujie and Yi, Martin and Aftandilian, Catherine C and Beauchemin, Melissa P and Cunningham, Christine and Larimer, Emily and Oberg, Jennifer and May, Benjamin L and Morse, Keith and Natarajan, Karthik and Noyd, David and Soucek, Vicki and Khurana, Rhea K and Sim, Phil and Guo, Lin Lawrence and Sung, Lillian},
title = {Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/cam4.72459}
}
EUVIMED